Stay updated on Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now displays a new revision tag, v3.6.5, replacing the previous v3.6.4 revision tag.
    Difference
    0.0%
    Check dated 2026-08-08T17:02:02.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.3 to v3.6.4, indicating a small version update to the page/template. This reflects a backend/content management update rather than a user-facing content change.
    Difference
    0.0%
    Check dated 2026-07-25T07:47:07.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.2 to v3.6.3, indicating a software/content management update. The study details and visible content appear unchanged.
    Difference
    0.0%
    Check dated 2026-07-03T22:21:04.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page revision metadata was updated from v3.6.0 to v3.6.2, indicating a newer version of the page. This update represents a minor documentation revision and does not alter study details, eligibility criteria, or outcomes.
    Difference
    0.0%
    Check dated 2026-06-27T00:02:01.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page introduces new user-help sections and explicitly states recruitment changes, and it also includes a formatting update to the Intervention/Treatment label along with a Revision: v3.6.0 tag.
    Difference
    0.4%
    Check dated 2026-06-12T16:44:01.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The study page now shows a revised version tag (v3.5.5), replacing the previous v3.5.4. This indicates a small publishing or backend update rather than a substantive change to the trial details.
    Difference
    0.0%
    Check dated 2026-06-05T13:13:40.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page.